Table 1 The characteristics and outcomes of patients underwent cryopablation with or without preoperativeliiodol marking
Preoperative lipiodol marking | (+) (n = 31) | (−) (n = 11) | p value | |
|---|---|---|---|---|
Mean age (year, range) | 74 (31–91) | 71.5 (31–86) | 71.1 (49–91) | NS |
Gender (%) | NS | |||
Male | 33 (79%) | 27 | 6 | |
Female | 9 (21%) | 5 | 4 | |
Laterality (%) | NS | |||
Right | 21 (50%) | 15 | 6 | |
Left | 21 (50%) | 16 | 5 | |
Tumor size (mm) | 24.1 (10–42) | 27.8 (10–42) | 21.3 (15–34) | p < 0.05 |
Biopsy performed in 36/42 (85.7%) | 28 | 8 | NS | |
RCC | 30 (87%) | 24 | 6 | |
AML | 1 (4%) | 0 | 1 | |
Inappropriate sample | 5 (9%) | 4 | 1 | |
PD (%) | 4 (36.4%) | 0 | 4 (36.4%) | p < 0.001 |
Post ablative hemorrhagic event (%) | 2 (18%) | 0 | 2 (18%) | p < 0.05 |